Get started
Award

UM1 AI148450

Funded outputs count: 18
Funder award ID: UM1 AI148450
OpenAlex ID: G9000000397
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials
2026 · Aaron Hudson, Scott Borgetti, et al. · Vaccine
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum
2025 · Flor M. Munoz, Lalitha Parameswaran, et al. · PEDIATRICS · 4
PDF
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
2025 · Robert L Atmar, Kirsten E Lyke, et al. · The Journal of Infectious Diseases · 4
Safety and Immunogenicity of an mRNA-1273 Booster in Children
2024 · Vladimir Berthaud, C Buddy Creech, et al. · Clinical Infectious Diseases · 10
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum
2024 · Flor M. Munoz, Richard Beigi, et al. · The Pediatric Infectious Disease Journal · 3
PDF
Altered spike IgG Fc N-linked glycans are associated with hyperinflammatory state in adult COVID and Multisystem Inflammatory Syndrome in Children
2024 · Jacob D. Sherman, Vinit Karmali, et al. · medRxiv
PDF
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
2024 · Kanal Singh, Kevin Rubenstein, et al. · The Journal of Infectious Diseases · 15
PDF
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
2024 · Cristina V. Cardemil, Yi Cao, et al. · PEDIATRICS · 29
PDF
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
2023 · Kirsten E. Lyke, Robert L. Atmar, et al. · npj Vaccines · 33
PDF
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
2023 · Flor M. Munoz, Christine M. Posavad, et al. · Vaccine · 41
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
2023 · Ana M Ortega-Villa, Noreen A Hynes, et al. · Open Forum Infectious Diseases · 2
PDF
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial
2022 · Gail E. Potter, Tyler Bonnett, et al. · Annals of Internal Medicine · 7
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
2022 · Kirsten E. Lyke, Robert L. Atmar, et al. · Cell Reports Medicine · 153
Homologous and Heterologous Covid-19 Booster Vaccinations
2022 · Robert L. Atmar, Kirsten E. Lyke, et al. · New England Journal of Medicine · 656
PDF
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization
2021 · Jonathan Fintzi, Tyler Bonnett, et al. · Clinical Infectious Diseases · 16
PDF
Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data
2021 · Catharine I Paules, Shannon K Gallagher, et al. · Clinical Infectious Diseases · 16
PDF
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
2020 · Andre C. Kalil, Thomas F. Patterson, et al. · New England Journal of Medicine · 1,836
Remdesivir for the Treatment of Covid-19 — Final Report
2020 · John H. Beigel, Kay M. Tomashek, et al. · New England Journal of Medicine · 7,251
Year
Topic